MiRNAs participate in the diagnosis, pathogenesis and therapy of Parkinson's disease

Xuexin Lu1,2, Zhijie Cui3, Shuang Liu1

  • 1Department of Neurosurgery, Navy General Hospital, PLA, Beijing, China.

Insights

MicroRNAs (miRNAs) are key regulators in biological processes and are implicated in Parkinson's disease pathogenesis. This review explores their role in Parkinson's diagnosis and potential as therapeutic targets.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Neuroscience

Background:

  • MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression post-transcriptionally.
  • These molecules play critical roles in various cellular functions and biological processes.
  • Dysregulation of miRNAs is increasingly linked to complex diseases, including neurodegenerative disorders.

Purpose of the Study:

  • To review the biological characteristics of microRNAs.
  • To summarize current research on the role of miRNAs in Parkinson's disease pathogenesis.
  • To explore the potential of miRNAs in Parkinson's disease diagnosis and therapy.

Main Methods:

  • Literature review of scientific articles on microRNAs and Parkinson's disease.
  • Analysis of studies investigating miRNA involvement in cellular metabolism and neurological function.
  • Synthesis of findings related to miRNA biomarkers and therapeutic strategies.

Main Results:

  • MicroRNAs regulate metabolic enzymes crucial for cellular function.
  • Evidence suggests a significant role for miRNAs in the progression of Parkinsonism.
  • Specific miRNAs show potential as diagnostic indicators for Parkinson's disease.

Conclusions:

  • MicroRNAs are pivotal in the pathogenesis of Parkinson's disease.
  • Further research into miRNAs could lead to novel diagnostic tools.
  • MicroRNAs represent a promising avenue for future Parkinson's disease therapeutics.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.1K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.6K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.3K